EN DE
STOCK COMPARISON

Interpace Biosciences vs Thermo Fisher Scientific: Fair Value & Quality

Both stocks run through our valuation models. Here is how Interpace Biosciences (IDXG) and Thermo Fisher Scientific (TMO) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the more attractively valued of the two: Interpace Biosciences trades at $6.51 versus a fair value of $3.30 (-49%), while Thermo Fisher Scientific trades at $678 versus $686 (+1%).
Interpace Biosciences
IDXG · USD · Health Care
-49%
upside to fair value
overvalued
Price$6.51
Fair Value$3.30
Quality64/100
Thermo Fisher Scientific
TMO · USD · Health Care
+1%
upside to fair value
fairly valued
Price$678
Fair Value$686
Quality62/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Interpace BiosciencesThermo Fisher Scientific
Valuation
1.9×P/E (TTM)36.2×
1.27×P/S (TTM)5.43×
2.06×P/B4.71× · book value is mostly goodwill
10.6×EV/EBITDA23.7×
0.36×PEG1.96×
−49.3%Fair value upside+1.1%
n/aDividend yield0.3%
n/aDividend per share$1.80
Profitability
12%Operating margin19%
n/aEBIT margin trend (5Y)0.74×
214%Return on equity14%
11%Return on assets5%
Growth
-22%Revenue growth (YoY)11%
6.7%Avg. growth/yr (3Y)-0.3%
3.6%Avg. growth/yr (5Y)6.7%
n/aValue creation/yr+2.6%
Balance & size
24.3×Interest coverage (EBIT/interest)5.7×
0.19×Debt / equity0.67×
$46MMarket cap$252B
expensiveGrowth qualityhealthy

Interpace Biosciences leads: 8 to 4 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Interpace Biosciencesof which business quality 64 · market factors 36 Thermo Fisher Scientificof which business quality 60 · market factors 82
ProfitabilityMargins and returns on capital today
97
43
Quality GrowthAre margins and returns improving?
47
31
CashflowEarnings quality: real cash, not paper profit
55
62
Fin. StrengthBalance sheet, leverage, solvency risk
49
60
InvestmentDisciplined investing over empire-building
50
79
Low VolatilityCalm price path (market factor)
44
69
MomentumPrice trend over the last 3–12 months (market factor)
7
84
52W MomentumDistance to the 52-week high (market factor)
75
92
Net IssuanceShare count: buybacks or dilution?
74
97

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyInterpace BiosciencesPrice $6.51Thermo Fisher ScientificPrice $678
DCF Models-56%below the price$2.88-39%below the price$413
Earnings-Based-28%below the price$4.68-70%below the price$204
Multiples-53%below the price$3.04-54%below the price$310
Asset-Based-92%below the price$0.54-86%below the price$96.78
Growth DCF-59%below the price$2.65-47%below the price$361
Economic Profit-30%below the price$4.58-74%below the price$177
Growth Earnings+154%above the price$16.51-49%below the price$343
Minimum-92%below the price$0.54-86%below the price$96.78
Maximum+154%above the price$16.51-39%below the price$413
Median-53%below the price$3.04-54%below the price$310
Geometric mean-49%below the price$3.32-64%below the price$246

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Interpace Biosciences: 17 of 24 models see the stock below the current price.

Thermo Fisher Scientific: 24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Interpace Biosciences
Price $6.51
Fair Value $3.30
Bear $2.26Bull $4.17
Thermo Fisher Scientific
Price $678
Fair Value $686
Bear $414Bull $892

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Interpace Biosciences · Health Care

Quality score64 · Top 25%
Fair value upside-49% · below median

Thermo Fisher Scientific · Health Care

Quality score62 · above median
Fair value upside+1% · above median

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the more attractively valued of the two: Interpace Biosciences trades at $6.51 versus a fair value of $3.30 (-49%), while Thermo Fisher Scientific trades at $678 versus $686 (+1%).

Interpace Biosciences has the higher quality score (64/100).

Open Thermo Fisher Scientific live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.